Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ECARX Holdings (ECX) Research & Development: 2021-2024

Historic Research & Development for ECARX Holdings (ECX) over the last 4 years, with Dec 2024 value amounting to $172.6 million.

  • ECARX Holdings' Research & Development rose 45.82% to -$25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$344.7 million, marking a year-over-year increase of 14.00%. This contributed to the annual value of $172.6 million for FY2024, which is 3.53% down from last year.
  • Latest data reveals that ECARX Holdings reported Research & Development of $172.6 million as of FY2024, which was down 3.53% from $178.9 million recorded in FY2023.
  • ECARX Holdings' 5-year Research & Development high stood at $198.5 million for FY2022, and its period low was $172.6 million during FY2024.
  • Over the past 3 years, ECARX Holdings' median Research & Development value was $178.9 million (recorded in 2023), while the average stood at $183.3 million.
  • In the last 5 years, ECARX Holdings' Research & Development grew by 5.85% in 2022 and then decreased by 9.87% in 2023.
  • MRY analysis of 4 years shows ECARX Holdings' Research & Development stood at $187.5 million in 2021, then rose by 5.85% to $198.5 million in 2022, then decreased by 9.87% to $178.9 million in 2023, then fell by 3.53% to $172.6 million in 2024.
  • Its last three reported values are $172.6 million in FY2024, $178.9 million for FY2023, and $198.5 million during FY2022.